Results 121 to 130 of about 17,598 (187)

Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during <i>in vitro</i> cultivation. [PDF]

Oncol Rep
Nojszewski J, Schröder NO, Clüver J, Holler J, Ahmeti H, Synowitz M, Held-Feindt J.   +6 more
europepmc   +1 more source

Immunosuppressive tumor microenvironment shape pancreatic cancer unresponsive to current immunotherapies. [PDF]

World J Clin Oncol
Li ZY, Peng SY, Li FL, Cai HQ.
europepmc   +1 more source

Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance. [PDF]

Cancer Drug Resist
Shen Y, Sun Y, Li X, Wang Y, Huang T, Li T, Zhu YZ, Hu L, Xu C.   +8 more
europepmc   +1 more source

Platelets in the tumor microenvironment: potential mediators of immune exclusion and resistance to immune checkpoint inhibitor therapy. [PDF]

Cell Oncol (Dordr)
Nasir Kansestani A, Zare ME, Zhang J.
europepmc   +1 more source

Tumor-associated macrophages: from basic research to clinical application [PDF]

, 2017

core   +1 more source

Exploring the prognostic molecular mechanisms of medulloblastoma through methylation-transcriptome integration. [PDF]

SAGE Open Med
Tuerxun K, Ji W, Tukebai T, Liu D, Zhao J, Wang Y.   +5 more
europepmc   +1 more source

The tumor microenvironment in leukemia: molecular pathways of immune evasion. [PDF]

Front Immunol
Zhu Y, Liu J, Qiu F, You Z, Liu Z, Zeng J, Zhong J, Song Z, Zhang S, Lu J, Jiang Y, Liu J, Yan Z, Lu C.   +13 more
europepmc   +1 more source

Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico. [PDF]

Int J Mol Sci
Davydenko VS, Shchemelev AN, Ostankova YV, Anufrieva EV, Totolian AA.   +4 more
europepmc   +1 more source

The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy. [PDF]

Cancer Commun (Lond)
Lv Y, Duan T, Song J, Liu S, Zhou Z, Ba Y, Weng S, Zuo A, Xu H, Luo P, Cheng Q, Zhang C, Ning J, Chen Y, Zhang Y, Liu Z, Han X.   +16 more
europepmc   +1 more source

Expression of the CXCR4 S338X Variant Improves Anti-Leukemia Efficacy of Anti-CD19 CAR-T Cells. [PDF]

Cancer Sci
Mao Y, Wang X, Jin CH, Wei Z, Ding Q, Zhang KK, Dong BW, Zheng KW, Hou Y, Zhang T, Zhao WJ, Hu Z, Yang YG.   +12 more
europepmc   +1 more source